These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
453 related items for PubMed ID: 11474829
1. Clinical validity of a self-test fructosamine in outpatient diabetic management. Cefalu WT, Wang ZQ, Redmon E, Bell-Farrow AD, McBride D, King T. Diabetes Technol Ther; 1999; 1(4):435-41. PubMed ID: 11474829 [Abstract] [Full Text] [Related]
2. Multisite evaluation of a new diabetes self-test for glucose and glycated protein (fructosamine). Edelman SV, Callahan P, Deeb LC. Diabetes Technol Ther; 2000; 2(2):233-8. PubMed ID: 11469264 [Abstract] [Full Text] [Related]
3. Fructosamine, hemoglobin A1c, and measures of diabetic control. Hom F. Diabetes Technol Ther; 1999; 1(4):443-5. PubMed ID: 11474830 [No Abstract] [Full Text] [Related]
4. A prospective, randomized, multicentered controlled trial to compare the annual glycemic and quality outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care. Lindsey CC, Carter AW, Mangum S, Greene D, Richardson A, Brown SJ, Essary JL, McCandless B. Diabetes Technol Ther; 2004 Jun; 6(3):370-7. PubMed ID: 15198841 [Abstract] [Full Text] [Related]
5. Determination of reference values for a novel ketoamine-specific fructosamine assay for assessment of diabetic glycemic control. O'Brien JE, Brookes M. Diabetes Technol Ther; 1999 Jun; 1(4):447-55. PubMed ID: 11474831 [Abstract] [Full Text] [Related]
6. A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: a 3-month interim analysis. Lindsey CC, Carter AW, Mangum S, Greene D, Richardson A, Brown S, McCandless B. Diabetes Technol Ther; 2002 Jun; 4(5):637-42. PubMed ID: 12450445 [Abstract] [Full Text] [Related]
7. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A. Clin Biochem; 2007 Dec; 40(18):1398-405. PubMed ID: 17919531 [Abstract] [Full Text] [Related]
8. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Vos FE, Schollum JB, Coulter CV, Manning PJ, Duffull SB, Walker RJ. Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672 [Abstract] [Full Text] [Related]
9. Performance of non-traditional hyperglycemia biomarkers by chronic kidney disease status in older adults with diabetes: Results from the Atherosclerosis Risk in Communities Study. Jung M, Warren B, Grams M, Kwong YD, Shafi T, Coresh J, Rebholz CM, Selvin E. J Diabetes; 2018 Apr; 10(4):276-285. PubMed ID: 29055090 [Abstract] [Full Text] [Related]
10. Usefulness of fructosamine for monitoring outpatients with diabetes. Austin GE, Wheaton R, Nanes MS, Rubin J, Mullins RE. Am J Med Sci; 1999 Nov; 318(5):316-23. PubMed ID: 10555094 [Abstract] [Full Text] [Related]
11. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Parrinello CM, Selvin E. Curr Diab Rep; 2014 Nov; 14(11):548. PubMed ID: 25249070 [Abstract] [Full Text] [Related]
12. A comparison of home glucose monitoring with determinations of hemoglobin A1c, total glycated hemoglobin, fructosamine, and random serum glucose in diabetic patients. Gebhart SS, Wheaton RN, Mullins RE, Austin GE. Arch Intern Med; 1991 Jun; 151(6):1133-7. PubMed ID: 2043015 [Abstract] [Full Text] [Related]
13. Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort. Malmström H, Walldius G, Grill V, Jungner I, Gudbjörnsdottir S, Hammar N. PLoS One; 2014 Jun; 9(10):e111463. PubMed ID: 25353659 [Abstract] [Full Text] [Related]
14. The interrelationships of glycemic control measures: HbA1c, glycated albumin, fructosamine, 1,5-anhydroglucitrol, and continuous glucose monitoring. Beck R, Steffes M, Xing D, Ruedy K, Mauras N, Wilson DM, Kollman C, Diabetes Research in Children Network (DirecNet) Study Group. Pediatr Diabetes; 2011 Dec; 12(8):690-5. PubMed ID: 21496193 [Abstract] [Full Text] [Related]
15. [Correlation of the Levels of Fructosamine and Glycated Hemoglobin with the Blood Glucose Profile in Pregnant Women with Diabetes Mellitus]. Fujimoto CY, da Costa RA, Zaccara Tde A, Paganotti Cde F, Francisco RP. Rev Bras Ginecol Obstet; 2016 Jan; 38(1):20-6. PubMed ID: 26814690 [Abstract] [Full Text] [Related]
17. A comparison of fructosamine and HbA1c for home self-monitoring blood glucose levels in type 2 diabetes. Chen HS, Chen RL, Chang ZY, Li HD. Zhonghua Yi Xue Za Zhi (Taipei); 2002 Apr; 65(4):151-5. PubMed ID: 12135193 [Abstract] [Full Text] [Related]
18. Results of a Study Comparing Glycated Albumin to Other Glycemic Indices. Desouza CV, Holcomb RG, Rosenstock J, Frias JP, Hsia SH, Klein EJ, Zhou R, Kohzuma T, Fonseca VA. J Clin Endocrinol Metab; 2020 Mar 01; 105(3):677-87. PubMed ID: 31650161 [Abstract] [Full Text] [Related]
19. Continuous Glucose Monitoring and Use of Alternative Markers To Assess Glycemia in Chronic Kidney Disease. Zelnick LR, Batacchi ZO, Ahmad I, Dighe A, Little RR, Trence DL, Hirsch IB, de Boer IH. Diabetes Care; 2020 Oct 01; 43(10):2379-2387. PubMed ID: 32788282 [Abstract] [Full Text] [Related]
20. Comparison of fructosamine with glycated hemoglobin as an index of glycemic control in diabetic patients. Guillausseau PJ, Charles MA, Godard V, Timsit J, Chanson P, Paolaggi F, Peynet J, Eschwege E, Rousselet F, Lubetzki J. Diabetes Res; 1990 Mar 01; 13(3):127-31. PubMed ID: 2091880 [Abstract] [Full Text] [Related] Page: [Next] [New Search]